Creative BioMart to Present at
                        BIO-Europe Spring Creative BioMart to Present at AACR Annual Meeting|Apr. 5-10, 2024|Booth #2953

BORA

bora, aurora kinase A activator

BORA; bora, aurora kinase A activator; C13orf34, chromosome 13 open reading frame 34; protein aurora borealis; FLJ22624; Aurora borealis; BORA_HUMAN; C13orf34; Chromosome 13 open reading frame 34; HsBora; RP11-342J4.2; OTTHUMP00000018495;

SLC4A11

solute carrier family 4, sodium borate transporter, member 11

SLC4A11; solute carrier family 4, sodium borate transporter, member 11; CDPD1, CHED2, corneal dystrophy and perceptive deafness 1 , corneal endothelial dystrophy 2 (autosomal recessive) , solute carrier family 4, sodium bicarbonate transporter like, me;

6720463M24Rik

bora, aurora kinase A activator

Worldwide Blockbusters' Movements (Alliance and Collaboration within this December)

On Dec. 20, 2012, CEVEC Pharmaceuticals (CEVEC), the developer of a novel human expression system derived from amniocytes, and Yuhan Corporation (Yuhan) based in Seoul, South Korea announced the signing of a CAP-Technology license agreement. The license will enable Yuhan to utilize CEVEC's CAP-T and...

Worldwide Blockbusters’ Movements (Alliance and Collaboration within this December)

On Dec. 20, 2012, CEVEC Pharmaceuticals (CEVEC), the developer of a novel human expression system derived from amniocytes, and Yuhan Corporation (Yuhan) based in Seoul, South Korea announced the signing of a CAP-Technology license agreement. The license will enable Yuhan to utilize CEVECs CAP-T...

Collaboration between Bio Service Provider and Biotech Company on Biospecific Cancer Antibodies

On Jan. 14, 2013, OcellO B.V., providing drug discovery screening services with its 3D cell culture-based screening platform, and Merus B.V., a biotech company, like Creative BioMart , offering specific antibodies and recombinant antibodies to help research, have entered into collaboration....

MorphoSys AG Collaborates with Heptares Therapeutics on GPCRs

On Feb., MorphoSys AG and the UK-based Heptares Therapeutics signed alliance to discover and develop novel antibody therapeutics targeting G protein-coupled receptors ( GPCRs ) , cataloged in membrane proteins that involve in a broad range of biological processes and diseases. ...

Another Forward Step of Laboratory Standardization in Diagnostic Procedure

In medical transplant cases, finding allogeneic stem cells are one challenge, according to the statistics, there are about 50,000 people a year urgently require a stem cell transplant; while another challenge is the precision and speed of detecting the difference between donors and recipient whi...

Soligenix Collaborates with Intrexon on Promoting Monoclonal Antibody Therapy for Melioidosis

On May 1, 2013, Soligenix, Inc., a biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures announced its collaboration between Intrexon to develop a treatment for Melioidosis. Intrexon is a synthetic biology company that utilizes its...

What Quality Collaboration Brings for Technology Transfer?

Collaborations and transferring technology between academic research groups and companies are commonly practiced in the biology-related field. In fact, many innovative therapies or medical/industrial/clinical techniques grow from research laboratories. But first Id like to express my opinion ...

logo

FOLLOW US

Terms and Conditions        Privacy Policy

Copyright © 2024 Creative BioMart. All Rights Reserved.

Contact Us

  • /

Stay Updated on the Latest Bioscience Trends